The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Hydrocodone Bitartrate and Acetaminophen
hydrocodone bitartrate and acetaminophen · HYDROCODONE BITARTRATE 7.5 mg/15mL; ACETAMINOPHEN 325 mg/15mL · Solution · Oral · Redpharm drug
NDC 67296-2093-01 · 118 mL in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 64950-0343-16) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.2771per unit
middle half $0.2082–$0.3498 · 5,189 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.2771
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
94%of plans cover it
tier 4 · prior auth 0% · step therapy 0% · qty limit 95%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for hydrocodone bitartrate and acetaminophen (other) in the next 90 days
price up 13% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- RedPharm DrugUnited Statesrepack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- ANDA040838
- TE code
- AA
- Approval date
- May 10, 2013
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of hydrocodone bitartrate and acetaminophen (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Genus Lifesciences Inc. | HYDROCODONE BITARTRATE 7.5 mg/15mL; ACETAMINOPHEN 325 mg/15mL | Aug 26, 2026 | Sep 3, 2026 |
| American Health Packaging | HYDROCODONE BITARTRATE 7.5 mg/15mL; ACETAMINOPHEN 325 mg/15mL | Aug 26, 2026 | Sep 2, 2026 |
| Cranbury Pharmaceuticals, LLC | HYDROCODONE BITARTRATE 10 mg/15mL; ACETAMINOPHEN 300 mg/15mL | Aug 26, 2026 | Sep 2, 2026 |
| Cranbury Pharmaceuticals, LLC | HYDROCODONE BITARTRATE 7.5 mg/15mL; ACETAMINOPHEN 325 mg/15mL | Aug 26, 2026 | Sep 2, 2026 |
| Eywa Pharma Inc | HYDROCODONE BITARTRATE 7.5 mg/15mL; ACETAMINOPHEN 325 mg/15mL | Aug 26, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | HYDROCODONE BITARTRATE 2.5 mg/5mL; ACETAMINOPHEN 108 mg/5mL | Aug 26, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | HYDROCODONE BITARTRATE 5 mg/10mL; ACETAMINOPHEN 217 mg/10mL | Aug 26, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | HYDROCODONE BITARTRATE 7.5 mg/15mL; ACETAMINOPHEN 325 mg/15mL | Aug 26, 2026 | Sep 2, 2026 |
| Redpharm drug | HYDROCODONE BITARTRATE 7.5 mg/15mL; ACETAMINOPHEN 325 mg/15mL | Aug 26, 2026 | Sep 2, 2026 |
| Redpharm Drug | HYDROCODONE BITARTRATE 7.5 mg/15mL; ACETAMINOPHEN 325 mg/15mL | Aug 26, 2026 | Sep 2, 2026 |
| Genus Lifesciences Inc. | HYDROCODONE BITARTRATE 325 mg/15mL; ACETAMINOPHEN 7.5 mg/15mL | Jul 22, 2026 | Aug 21, 2026 |
| American Health Packaging | HYDROCODONE BITARTRATE 325 mg/15mL; ACETAMINOPHEN 7.5 mg/15mL | Jul 22, 2026 | Aug 19, 2026 |
| Cranbury Pharmaceuticals, LLC | HYDROCODONE BITARTRATE 300 mg/15mL; ACETAMINOPHEN 10 mg/15mL | Jul 22, 2026 | Aug 19, 2026 |
| Cranbury Pharmaceuticals, LLC | HYDROCODONE BITARTRATE 325 mg/15mL; ACETAMINOPHEN 7.5 mg/15mL | Jul 22, 2026 | Aug 19, 2026 |
| Eywa Pharma Inc | HYDROCODONE BITARTRATE 325 mg/15mL; ACETAMINOPHEN 7.5 mg/15mL | Jul 22, 2026 | Aug 19, 2026 |
| PAI Holdings, LLC dba PAI Pharma | HYDROCODONE BITARTRATE 325 mg/15mL; ACETAMINOPHEN 7.5 mg/15mL | Jul 22, 2026 | Aug 19, 2026 |
| PAI Holdings, LLC dba PAI Pharma | HYDROCODONE BITARTRATE 108 mg/5mL; ACETAMINOPHEN 2.5 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| PAI Holdings, LLC dba PAI Pharma | HYDROCODONE BITARTRATE 217 mg/10mL; ACETAMINOPHEN 5 mg/10mL | Jul 22, 2026 | Aug 19, 2026 |
| Redpharm drug | HYDROCODONE BITARTRATE 325 mg/15mL; ACETAMINOPHEN 7.5 mg/15mL | Jul 22, 2026 | Aug 19, 2026 |
| Redpharm Drug | HYDROCODONE BITARTRATE 325 mg/15mL; ACETAMINOPHEN 7.5 mg/15mL | Jul 22, 2026 | Aug 19, 2026 |
| Genus Lifesciences Inc. | ACETAMINOPHEN 325 mg/15mL; HYDROCODONE BITARTRATE 7.5 mg/15mL | Jul 15, 2026 | Jul 19, 2026 |
| American Health Packaging | ACETAMINOPHEN 325 mg/15mL; HYDROCODONE BITARTRATE 7.5 mg/15mL | Jul 15, 2026 | Jul 15, 2026 |
| Cranbury Pharmaceuticals, LLC | ACETAMINOPHEN 325 mg/15mL; HYDROCODONE BITARTRATE 7.5 mg/15mL | Jul 15, 2026 | Jul 15, 2026 |
| Cranbury Pharmaceuticals, LLC | ACETAMINOPHEN 300 mg/15mL; HYDROCODONE BITARTRATE 10 mg/15mL | Jul 15, 2026 | Jul 15, 2026 |
| Eywa Pharma Inc | ACETAMINOPHEN 325 mg/15mL; HYDROCODONE BITARTRATE 7.5 mg/15mL | Jul 15, 2026 | Jul 15, 2026 |
| PAI Holdings, LLC dba PAI Pharma | ACETAMINOPHEN 217 mg/10mL; HYDROCODONE BITARTRATE 5 mg/10mL | Jul 15, 2026 | Jul 15, 2026 |
| PAI Holdings, LLC dba PAI Pharma | ACETAMINOPHEN 325 mg/15mL; HYDROCODONE BITARTRATE 7.5 mg/15mL | Jul 15, 2026 | Jul 15, 2026 |
| PAI Holdings, LLC dba PAI Pharma | ACETAMINOPHEN 108 mg/5mL; HYDROCODONE BITARTRATE 2.5 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
| Redpharm drug | ACETAMINOPHEN 325 mg/15mL; HYDROCODONE BITARTRATE 7.5 mg/15mL | Jul 15, 2026 | Jul 15, 2026 |
| Redpharm Drug | ACETAMINOPHEN 325 mg/15mL; HYDROCODONE BITARTRATE 7.5 mg/15mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Hydrocodone Bitartrate and Acetaminophen — NDC 67296-2093-01," retrieved September 3, 2026, https://drugdashboards.com/drug/67296209301.
Free to cite with attribution — see how the data is put together.